NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/15/2026
Back to search
Official data from USPTO
JOURNAL OF CLINICAL PATHWAYS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
JOURNAL OF CLINICAL PATHWAYS
ST13
US500000086583622Class
44
Filing
86583622
Registration
4924585
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/09/2026
Trademark type
Word
Nice classes
44
Filing date
04/01/2015
Registration date
03/22/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/15/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
08/14/2015
First use in commerce
08/14/2015
Drawing code
4
Owner type
16
Owner location
MALVERN, PA, US
Examiner
SINGH, TEJBIR
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HMP OMNIMEDIA, LLC
HMP Communications, LLC
Representatives
Michael R. Justus Carlton Fields, PA
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing online information in the medical and healthcare fields
Publications
History of USPTO decisions and trademark events.
42 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/15/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/15/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/15/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/11/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/06/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/22/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/21/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/13/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/13/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/05/2022
ES8R
TEAS SECTION 8 RECEIVED
02/02/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/22/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/21/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/21/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/21/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/21/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/21/2021
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/22/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/12/2016
ALIE
ASSIGNED TO LIE
02/10/2016
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/12/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2016
GNRT
NON-FINAL ACTION E-MAILED
01/11/2016
CNRT
NON-FINAL ACTION WRITTEN
01/11/2016
IUAA
USE AMENDMENT ACCEPTED
01/11/2016
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/09/2016
IUAF
USE AMENDMENT FILED
01/09/2016
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/08/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/09/2015
GNRT
NON-FINAL ACTION E-MAILED
07/09/2015
CNRT
NON-FINAL ACTION WRITTEN
07/09/2015
DOCK
ASSIGNED TO EXAMINER
07/09/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2015
NWAP
NEW APPLICATION ENTERED
04/04/2015
Continuous trademark protection
Get notified about every new filing that threatens JOURNAL OF CLINICAL PATHWAYS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.